#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis membranoproliferative Haemolytic uraemic syndrome Hypoxic-ischaemic encephalopathy Ocular lymphoma Juvenile idiopathic arthritis Paroxysmal nocturnal haemoglobinuria Thrombotic thrombocytopenic purpura Small cell lung cancer recurrent Congenital disorder of glycosylation Neuroendocrine tumour Ventricular tachycardia Colon cancer Chronic hepatitis B Endocrine ophthalmopathy Acute myeloid leukaemia recurrent More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Trials in Disease Glomerulonephritis rapidly progressive – Diagnostics Osteosarcoma Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Hereditary optic atrophy – Life with Disease Glycogen storage disease type II – Treatment Antithrombin III deficiency Burkitt’s lymphoma – Trials in Disease Haemophagocytic lymphohistiocytosis – Life with Disease Isodicentric chromosome 15 syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Terbinafine Hydrochloride Sotorasib OSIMERTINIB MESYLATE Larotrectinib Sulfate Bimekizumab Zibotentan Clotrimazole Tasquinimod Lansoprazole Eteplirsen Tx200-Tr101 Pivekimab Sunirine Dupilumab Ziltivekimab Leuprorelin Acetate Amsacrine Enalapril Immunglobulin Dactylis Glomerata Vitamin A Bp More therapies…

    Learn about Your Condition

    Dermatitis atopic Oesophageal atresia Cystic fibrosis lung Ependymoma malignant Fontan procedure Colorectal cancer metastatic Palmoplantar pustulosis Chronic hepatitis B Lymphatic malformation Penile cancer Monkeypox Renal injury Amyotrophic lateral sclerosis Small for dates baby Thalassaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Adenomatous polyposis coli

  • A study testing sirolimus to slow disease progression in patients with familial adenomatous polyposis

    Recruiting

    3 1
    Investigated Diseases:
    • Adenomatous polyposis coli
    Investigated Drugs:
    • Sirolimus
    Denmark Germany Italy The Netherlands Spain

  • Study of REC-4881 in Adults with Familial Adenomatous Polyposis to Assess Safety and Efficacy

    Not yet recruiting

    2 1
    Germany The Netherlands Spain

  • Study on the Safety of Sirolimus for Children with Familial Adenomatous Polyposis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Sirolimus
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!